Published in J Immunol on August 17, 2012
Loss and dysregulation of Th17 cells during HIV infection. Clin Dev Immunol (2013) 1.04
Islet inflammation: a unifying target for diabetes treatment? Trends Endocrinol Metab (2013) 1.02
A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice. Gastroenterology (2014) 1.01
The inducible costimulator augments Tc17 cell responses to self and tumor tissue. J Immunol (2015) 0.80
Human lymph-node CD8(+) T cells display an altered phenotype during systemic autoimmunity. Clin Transl Immunology (2016) 0.75
Peripheral Tc17 and Tc17/Interferon-γ Cells are Increased and Associated with Lung Function in Patients with Chronic Obstructive Pulmonary Disease. Chin Med J (Engl) (2016) 0.75
Mitochondrial DNA Activates the NLRP3 Inflammasome and Predisposes to Type 1 Diabetes in Murine Model. Front Immunol (2017) 0.75
Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity (2007) 3.61
Direct presentation of antigen by lymph node stromal cells protects against CD8 T-cell-mediated intestinal autoimmunity. Gastroenterology (2008) 2.00
An antigen-specific pathway for CD8 T cells across the blood-brain barrier. J Exp Med (2007) 1.84
Autoreactive CD8 T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention. Immunity (2002) 1.74
Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice. J Clin Invest (2003) 1.59
Foxp3+ CD25+ regulatory T cells specific for a neo-self-antigen develop at the double-positive thymic stage. Proc Natl Acad Sci U S A (2006) 1.47
Cutting edge: Multiple sclerosis-like lesions induced by effector CD8 T cells recognizing a sequestered antigen on oligodendrocytes. J Immunol (2008) 1.46
Role of enteric glial cells in inflammatory bowel disease. Glia (2003) 1.41
Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis. Nat Med (2009) 1.34
Cutting edge: V alpha 14-J alpha 281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice. J Immunol (2002) 1.31
Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation. J Exp Med (2005) 1.18
Unique effects of KIT D816V in BaF3 cells: induction of cluster formation, histamine synthesis, and early mast cell differentiation antigens. J Immunol (2008) 1.15
Pathogenesis of the immune reconstitution inflammatory syndrome in HIV-infected patients. Curr Opin Infect Dis (2012) 1.14
Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility. Brain (2011) 1.11
Pertussis toxin reduces the number of splenic Foxp3+ regulatory T cells. J Immunol (2006) 1.07
Pathogenesis of the immune reconstitution inflammatory syndrome affecting the central nervous system in patients infected with HIV. Brain (2011) 1.06
Invariant NKT cells inhibit development of the Th17 lineage. Proc Natl Acad Sci U S A (2009) 1.03
Therapeutic manipulation of iNKT cells in autoimmunity: modes of action and potential risks. Trends Immunol (2004) 1.01
Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models. Biochim Biophys Acta (2010) 1.00
EVER proteins, key elements of the natural anti-human papillomavirus barrier, are regulated upon T-cell activation. PLoS One (2012) 0.97
Cell-cell cooperation at the T helper cell/mast cell immunological synapse. Blood (2009) 0.95
Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models. Acta Neuropathol (2014) 0.93
Mast cells: new targets for multiple sclerosis therapy? J Neuroimmunol (2002) 0.93
CD8 T cell responses to myelin oligodendrocyte glycoprotein-derived peptides in humanized HLA-A*0201-transgenic mice. J Immunol (2007) 0.89
In situ evidence of JC virus control by CD8+ T cells in PML-IRIS during HIV infection. Neurology (2013) 0.89
Regulatory T cells in the control of inflammatory demyelinating diseases of the central nervous system. Curr Opin Neurol (2008) 0.88
Therapeutic use of CCR5 antagonists is supported by strong expression of CCR5 on CD8(+) T cells in progressive multifocal leukoencephalopathy-associated immune reconstitution inflammatory syndrome. Acta Neuropathol (2015) 0.86
Antigen-specific Treg impair CD8(+) T-cell priming by blocking early T-cell expansion. Eur J Immunol (2010) 0.84
Invariant NKT cells regulate experimental autoimmune encephalomyelitis and infiltrate the central nervous system in a CD1d-independent manner. J Immunol (2008) 0.84
A transgenic mouse model for T-cell ignorance of a glial autoantigen. J Autoimmun (2004) 0.83
An altered self-peptide with superagonist activity blocks a CD8-mediated mouse model of type 1 diabetes. J Immunol (2004) 0.82
Cutting edge: neuronal recognition by CD8 T cells elicits central diabetes insipidus. J Immunol (2012) 0.82
Insulin modulates protease-activated receptor 2 signaling: implications for the innate immune response. J Immunol (2010) 0.82
Immune tolerance and control of CNS autoimmunity: from animal models to MS patients. J Neurochem (2006) 0.82
The p.Arg63Trp polymorphism controls Vav1 functions and Foxp3 regulatory T cell development. J Exp Med (2011) 0.81
Mast cell transcripts are increased within and outside multiple sclerosis lesions. J Neuroimmunol (2008) 0.80
Insulin-regulated aminopeptidase and its compartment in dendritic cells. Mol Immunol (2012) 0.79
LF 15-0195 inhibits the development of rat central nervous system autoimmunity by inducing long-lasting tolerance in autoreactive CD4 T cells. J Immunol (2003) 0.79
Multimerized T cell epitopes protect from experimental autoimmune diabetes by inducing dominant tolerance. Proc Natl Acad Sci U S A (2007) 0.79
Invariant NKT cells exacerbate type 1 diabetes induced by CD8 T cells. J Immunol (2005) 0.79
Phosphorus-Based Dendrimer ABP Treats Neuroinflammation by Promoting IL-10-Producing CD4(+) T Cells. Biomacromolecules (2015) 0.78
Vaccine-associated inflammatory diseases of the central nervous system: from signals to causation. Curr Opin Neurol (2016) 0.78
T cell apoptosis and induction of Foxp3+ regulatory T cells underlie the therapeutic efficacy of CD4 blockade in experimental autoimmune encephalomyelitis. J Immunol (2012) 0.78
Maintaining or breaking CD8+ T-cell tolerance to beta islet cell antigens: lessons from transgenic mouse models. J Autoimmun (2004) 0.78
Recognition of a high affinity MHC class I-restricted epitope of myelin oligodendrocyte glycoprotein by CD8⁺ T cells derived from autoantigen-deficient mice. Front Immunol (2011) 0.76
Cytokine and cytokine receptor genes in the susceptibility and resistance to organ-specific autoimmune diseases. Adv Exp Med Biol (2003) 0.76
LF 15-0195 treatment protects against central nervous system autoimmunity by favoring the development of Foxp3-expressing regulatory CD4 T cells. J Immunol (2006) 0.75
Endothelial cells and lymphatics at the interface between the immune and central nervous systems: implications for multiple sclerosis. Curr Opin Neurol (2017) 0.75
Hepatic T Cell Tolerance Induction in An Inflammatory Environment. Dig Dis (2017) 0.75
Transgenic mouse models of multiple sclerosis. Cell Mol Life Sci (2010) 0.75